ARCHIVES

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

This article is from The Cancer Letter archive.

Vol. 29 No. 02 | January 10, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Entertainment: Wild Type Wins First, The Directors Second, In Battle of Bands

October 15, 1999

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974

The Tivozanib Timeline

May 10, 2013

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983